Whose Health Is It, Anyway?

ISBN : 9780198863458

Sally Davies; Jonathan Pearson-Stuttard
208 Pages
138 x 216 mm
Pub date
Nov 2020
Send mail

Covid-19 has shown how vulnerable society, our economy, and day-to-day lives are, but we have not valued the pivotal role of good health. Our healthcare system is now an illness service with little resilience, importing illness rather than exporting health into communities, not leveraging the digital technology innovations harnessed in other industries. Whose Health Is It, Anyway? outlines why health is truly our most untapped opportunity for prosperity and happiness in the 21st century, individually and jointly as whole nations. Through collectively valuing health - civil society and the private sector - we can radically change the wider health environment which will pay off for all. This book outlines how a 21st century healthcare system should expand the founding principles of the NHS, from illness to a true health service, and encompass a National Care Service. The authors outline the entities and processes that could underpin a new total health system, one that could serve to take us into a happier and more prosperous future.


About the authors
1 Introduction
2 Are we healthy? It's complicated
3 Is our whole health system ready for the future?
4 The social drivers of health
5 The commercial drivers of health
6 Shared values, shared health, shared prosperity
7 Does the healthcare system help or hinder our health?
8 The promise of technology
9 So whose health is it? Time to value total health

About the author: 

Professor Dame Sally C. Davies GCB, DBE, FRS, FMed Sci is a Haematologist by training who specialized in Sickle Cell Disease. She joined NHS Research and Development in 1998, as Regional Director for North-West Thames Region. She was appointed Director General for Research and Development in the Department of Health in 2004 serving until 2016. In that role she established the National Institute for Health Research, NIHR in 2006 and led its development as Inaugural Director until 2016. In 2010 she was asked to be interim Chief Medical Officer (CMO) and then became the CMO for England and Senior Medical Adviser to the UK Government in 2011. She was awarded a DBE in 2009 and GCB in the 2020 New Year Honours. She was elected a Fellow of the Royal Society in 2014 and a Member of the National Academy of Medicine, USA in 2015.; Dr Jonathan Pearson-Stuttard, FRSPH is a Public Health Physician and Epidemiologist at Imperial College London. After completing his medical training at the University of Oxford, he has been awarded multiple competitive clinical-academic from the National Institute for Health and Research and the Wellcome Trust. His research has two main streams spanning non-communicable disease epidemiology that uses big data and simulation modelling of health, economic and inequality outcomes to inform public health policy and investigates the increasing multimorbidity and diversification of patients with chronic diseases such as diabetes. He was Editor-in-Chief of the Chief Medical Officer's 2018 Report 'Health 2040; Better Health Within Reach', which made several key recommendations including the development of a Composite Health Index, currently being developed by the Office for National Statistics. He is now vice-Chair of the Royal Society for Public Health.

The price listed on this page is the recommended retail price for Japan. When a discount is applied, the discounted price is indicated as “Discount price”. Prices are subject to change without notice.